HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hongfu Sun Selected Research

Chemoradiotherapy

12/2023Do higher radiation doses improve survival for cervical esophageal squamous cell cancer patients treated with definitive chemoradiotherapy using intensity-modulated radiotherapy? A propensity-score matched analysis.
1/2023Sintilimab as maintenance treatment for local/regional recurrent esophageal squamous carcinoma after concurrent chemoradiotherapy: a single-arm Ib/II phase study.
1/2022Twice-daily thoracic radiotherapy by intensity-modulated radiation therapy (IMRT) compared with simultaneous integrated boost IMRT (SIB-IMRT) with concurrent chemotherapy for patients with limited-stage small cell lung cancer. A propensity-score matched analysis.
1/2020High dose radiation therapy based on normal tissue constraints with concurrent chemotherapy achieves promising survival of patients with unresectable stage III non-small cell lung cancer.
8/2017Individual isotoxic radiation dose escalation based on V20 and advanced technologies benefits unresectable stage III non-small cell lung cancer patients treated with concurrent chemoradiotherapy: long term follow-up.
12/2012Functional and biologic metrics for predicting radiation pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.
8/2012Serum superoxide dismutase, a potential predictor for radiation pneumonitis following chemoradiotherapy in non-small cell lung cancer patients.
9/2011Standard uptake value and metabolic tumor volume of ¹⁸F-FDG PET/CT predict short-term outcome early in the course of chemoradiotherapy in advanced non-small cell lung cancer.
8/2011Decline of serum CYFRA21-1 during chemoradiotherapy of NSCLC: a probable predictive factor for tumor response.
11/2010CYFRA21-1 can predict the sensitivity to chemoradiotherapy of non-small-cell lung carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hongfu Sun Research Topics

Disease

13Neoplasms (Cancer)
03/2024 - 08/2011
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 11/2010
6Esophageal Squamous Cell Carcinoma
01/2024 - 11/2009
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2024 - 08/2015
4Esophageal Neoplasms (Esophageal Cancer)
01/2024 - 01/2022
4Radiation Pneumonitis
01/2021 - 09/2011
3Multiple Sclerosis
03/2018 - 01/2015
2Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2024 - 12/2023
2Carcinoma (Carcinomatosis)
11/2023 - 11/2009
2Lung Neoplasms (Lung Cancer)
01/2022 - 11/2010
2Breast Neoplasms (Breast Cancer)
01/2021 - 03/2014
2Demyelinating Diseases (Demyelinating Disease)
03/2018 - 11/2017
1Neoplasm Metastasis (Metastasis)
04/2024
1Parkinson Disease (Parkinson's Disease)
11/2023
1Glioma (Gliomas)
03/2023
1Disease Progression
01/2023
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2023
1Prostatic Neoplasms (Prostate Cancer)
12/2022
1Brain Neoplasms (Brain Tumor)
12/2022
1Esophageal Fistula
02/2022
1Human Influenza (Influenza)
01/2022
1Crazy paving pattern
01/2022
1COVID-19
01/2022
1Pulmonary Atelectasis
01/2022
1Emphysema
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Hyperoxia
12/2020
1Hypercapnia
12/2020
1Hemorrhage
01/2020
1Relapsing-Remitting Multiple Sclerosis
08/2019
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2018
1Alcoholism (Alcohol Abuse)
01/2017
1Lymphatic Metastasis
05/2010

Drug/Important Bio-Agent (IBA)

8IronIBA
11/2023 - 01/2015
3Immune Checkpoint InhibitorsIBA
12/2022 - 01/2022
2Therapeutic UsesIBA
04/2024 - 11/2010
2Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2009
1Niacin (Nicotinic Acid)FDA LinkGeneric
03/2023
1ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
03/2023
1raltitrexed (D 1694)IBA
01/2023
1sintilimabIBA
01/2023
1AndrogensIBA
12/2022
1LigandsIBA
12/2022
1C-Reactive ProteinIBA
01/2022
1Oxygen (Dioxygen)IBA
12/2020
1CalciumIBA
03/2018
1Cisplatin (Platino)FDA LinkGeneric
02/2016
1Vinorelbine (Navelbine)FDA LinkGeneric
02/2016
1Coloring Agents (Dyes)IBA
01/2015
1Superoxide DismutaseIBA
08/2012
1ImmunosorbentsIBA
08/2011
1Keratin-19 (Keratin 19)IBA
08/2011
1EnzymesIBA
08/2011
1Tumor Biomarkers (Tumor Markers)IBA
08/2011
1Carcinoembryonic AntigenIBA
08/2011
1Phosphopyruvate Hydratase (Enolase)IBA
08/2011
1AntigensIBA
08/2011
1Biological FactorsIBA
08/2010

Therapy/Procedure

12Radiotherapy
04/2024 - 09/2011
12Chemoradiotherapy
12/2023 - 11/2009
9Therapeutics
04/2024 - 11/2010
8Drug Therapy (Chemotherapy)
01/2023 - 01/2020
3Immunotherapy
01/2024 - 01/2022
3Neoadjuvant Therapy
01/2024 - 01/2022
2Segmental Mastectomy (Lumpectomy)
07/2021 - 01/2021
1Adjuvant Radiotherapy
03/2024
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
12/2023
1Traction
01/2022
1Esophagectomy
05/2010